性能参数

产品名称

Taurodeoxychloic Acid sodium hydrate

规格

10mM*1mL in DMSO 10mg 50mg 100mg 200mg

货号

GOY-Y3053

 含量

>98.00%

CAS

110026-03-4

别名

N/A

化学名

N/A

分子式

C26H47NNaO7S+

分子量

分子量 540.71

溶解度

DMSO: 125 mg/mL (231.61 mM)

储存条件

Store at -20°C

General tips

用途

仅供科研

价格

电询

详细内容

Taurodeoxychloic Acid (sodium hydrate) prevents apoptosis by blocking a calcium-mediated apoptotic pathway as well as caspase-12 activation. Taurodeoxychloic Acid (sodium hydrate) is investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis[1]. Caspase-12

Taurodeoxychloic Acid (TUDCA) is neuroprotective in a transgenic animal model of Huntington's disease[2].

[1]. Xie Q, et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 2002 Sep;36(3):592-601. [2]. Keene CD, et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10671-6.

2-氨基-4,6-二甲氧基嘧啶 98%  二氧化钛 99.995% metals basis

2-氨基-4，6-二氯嘧啶 98%  二氧化钛 AR,99.0%

3-羟基 98%  二氧化钛 SP

2-氯 99%  氧化铽 99.9% metals basis

4,6-二氯-2-甲基嘧啶 98%  氧化铽 99.99% metals basis

2,4-二氯嘧啶 98%  氧化铽 99.999% metals basis

Senicapoc10mg 50mg 100mg 200mg 500mg>98.00%Cas No. 289656-45-7C20H15F2NO

Sodium Channel inhibitor 12mg 5mg 10mg 50mg 100mg>98.00%Cas No. 1198117-23-5C24H19F4N3O3

SSD114 hydrochloride1mg 5mg 10mg 50mg 100mg>98.00%Cas No. N/AC18H21ClF3N3O

Tegoprazan5mg 10mg 25mg 50mg 100mg>98.00%Cas No. 942195-55-3C20H19F2N3O3

Tebanicline hydrochloride5mg 10mg 25mg 50mg 100mg>98.00%Cas No. 203564-54-9C9H12Cl2N2O

Tebanicline dihydrochloride5mg 10mg 25mg 50mg 100mg>98.00%Cas No. 209326-19-2C9H13Cl3N2O

TPC2-A1-N5mg 10mg 25mg 50mg 100mg>98.00%Cas No. 136186-07-7C17H9Cl2F3N2O2